Sleep apnea doesn’t have an effect on the visible outcomes of thyroid eye illness therapy

The of obstructive sleep apnea (OSA) was not associated with visual outcomes in thyroid eye disease (TED) patients who received orbital decompression therapy, researchers found in a report presented at the American Society’s 52nd Annual Fall Scientific Symposium of Ophthalmic Plastic and Reconstructive Surgery was presented in New Orleans, November 11-12. November.

TED symptoms become more severe in patients with TED, and a higher of OSA is identified by STOP-BANG scores, previous research has shown. However, it has not yet been investigated whether OSA status is associated with outcomes of orbital decompression in patients with TED.

The study included 57 patients (83 eyes, mean age 53.7 ± 15.7 years, 41 ) with TED who underwent orbital decompression in a single tertiary center between 2010 and 2020. Based on the STOP-BANG score, they were classified according to low-risk OSA (0 to 2.72% of patients), medium-risk OSA (3 or 4, 14%) and high-risk OSA (score greater than 5, 14%).

Continue reading

Before the operation (31 bilateral, 26 unilateral) the visual acuity was 0.24 ± 31 (20/34) for low risk, 0.31 ± 0.19 (20/40) for medium risk and 0.23 ± 0.16 (20/33) for high-risk OSA patients (P = .71).

The best corrected visual acuity (BCVA) was measured before the operation and at the following times: less than 1 month, 1 to 3 months, 3 to 6 months, 6 to 9 months and 9 to 12 months after the operation.

At 9 to 12 months follow-up, the researchers found visual acuity to be 0.10 ± 0.10 (20/25) for low risk, 0.19 ± 0.10 (20/30) for medium risk, and 0, 27 ± 0.17 (20/25). 37) for high-risk OSA patients (P = .08).

Visual results in the 1st year after surgery were not related to OSA status. The in patients with low OSA risk with a higher BCVA approximately 9 to 12 months postoperatively compared to patients with medium or high OSA risk was not statistically significant.

Disclosure: A study author stated to have links with biotech, pharmaceutical and / or device manufacturers. For a full list of author disclosures, see the original reference.


Gervasio KA, McKnight T., Xu V, et al. The effect of obstructive sleep apnea risk on visual outcomes in patients with thyroid eye disease after orbital decompression. Poster presented at ASOPRS 52nd Annual Fall Scientific Symposium; 11.-12. November 2021; New Orleans, LA.

This article originally appeared on Ophthalmology Advisor

Leave a comment

Your email address will not be published. Required fields are marked *